Skip to main content

Table 1 Patient characteristics

From: Long-term outcomes of concomitant tricuspid valve repair in patients undergoing mitral valve surgery

  All patients documented PS matched cohort
Total
N = 1357
Isolated MVS
N = 1165
MVS + TVR
N = 192
p-value Isolated MVS
N = 182
MVS + TVR
N = 182
p-value
Age (years) 63.9 ± 12.3 63.0 ± 12.5 69.2 ± 10.1 < 0.001 69.4 ± 10.9 68.9 ± 10.2 0.623
Female gender, % 43.3 40.9 58.3 < 0.001 57.7 57.7 1.000
Body mass index (kg/m2) 26.4 ± 4.7 26.4 ± 4.6 26.3 ± 5.1 0.807 26.1 ± 25.7 26.3 ± 5.1 0.716
Cardiovascular risk factors
 Hypertension, % 53.7 53.2 56.8 0.360 51.6 57.1 0.292
 Dyslipidaemia, % 16.8 17.2 14.7 0.390 13.7 15.5 0.640
 Diabetes mellitus, % 8.7 8.0 13.0 0.022 9.9 13.7 0.256
Comorbidities - general
 Creatinine (mg/dL) 1.0 ± 0.5 1.0 ± 0.4 1.1 ± 0.6 < 0.001 1.1 ± 0.4 1.1 ± 0.5 0.518
 Kidney failure (Cr > 2.26 mg/dL), % 1.7 1.3 4.2 0.010 3.3 3.3 1.000
 Stroke, % 5.5 5.3 6.3 0.600 4.9 6.0 0.645
 COPD, % 11.8 11.7 12.5 0.742 11.0 12.6 0.626
 PAD, % 3.0 2.7 4.7 0.145 4.4 4.4 1.000
Comorbidity – cardiac
 Atrial fibrillation, % 32.4 28.3 57.6 < 0.001 48.9 56.0 0.172
 Coronary artery disease, % 10.2 9.9 12.5 0.266 12.6 12.6 1.000
 Myocardial infarction (≤90 days), % 0.7 0.6 1.0 0.371 0.0 1.1 0.499
 Prior aortic valve replacement, % 2.1 1.4 6.3 < 0.001 2.2 3.8 0.358
 Prior CABG, % 3.9 3.5 6.3 0.070 7.1 5.5 0.518
 Prior pacemaker, % 2.2 1.6 5.8 0.002 2.7 6.0 0.125
 NYHA class III / IV, % 75.5 72.6 92.2 < 0.001 96.2 92.9 0.168
 CCS class III / IV, % 4.1 3.9 5.2 0.381 5.5 5.5 1.000
 Pulmonary hypertension, % 12.0 11.3 16.7 0.033 12.6 15.9 0.369
Emergency indication for surgery, % 3.9 4.3 1.6 0.070 1.1 1.6 1.000
Log EuroSCORE I, % 3.8 [1.9–9.0] 3.4 [1.6–7.8] 8.0 [4.0–14.3] < 0.001 6.6 [3.3–14.3] 7.4 [3.9–12.4] 0.699
  1. Legend: values represent percentage, mean ± SD or median [IQR]. CABG coronary artery bypass graft, CCS Canadian Cardiovascular Society, COPD chronic obstructive pulmonary disease, Cr creatinine, IQR interquartile range, NYHA New York Heart Association, PAD peripheral artery disease, SD standard deviation